⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9989664 | 0.76 | — | — | |
| SCHEMBL33524954 | 0.75 | — | — | |
| SCHEMBL10990 | 0.75 | — | — | |
| SCHEMBL703169 | 0.75 | — | — | |
| SCHEMBL1599522 | 0.75 | — | — | |
| SCHEMBL715867 | 0.75 | GSK3B (1.00) | — | |
| SCHEMBL7021498 | 0.75 | — | — | |
| SCHEMBL693917 | 0.75 | GSK3B (1.00) | — | |
| Charcoal, Activated SCHEMBL8357494 | 0.72 | — | — | |
| Ammonia Solution, Strong SCHEMBL4263587 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719352-A1 | LIPID NANOPARTICLE FORMULATIONS AND COMPOSITIONS | Capstan Therapeutics, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| WO-2025096878-A1 | RNA FOR IN VIVO TRANSFECTION WITH INCREASED EXPRESSION | CAPSTAN THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2024249954-A9 | LIPID NANOPARTICLE FORMULATIONS AND COMPOSITIONS | CAPSTAN THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2024249954-A1 | LIPID NANOPARTICLE FORMULATIONS AND COMPOSITIONS | CAPSTAN THERAPEUTICS, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| CN-105514440-B | The lithium ion battery of negative electrode material and the application negative electrode material | 江苏华东锂电技术研究院有限公司 | 2019-06-18 | — | — | CN | claimed |
| US-10202455-B2 | Molecular constructs with targeting and effector moieties comprising an SCFV specific for ectodomain of transferrin-1 receptor and fingolimod | Immunwork Inc. (TW) | 2019-02-12 | — | — | US | claimed |
| CN-105576245-B | Lithium ion battery | 江苏华东锂电技术研究院有限公司 | 2018-10-26 | — | — | CN | claimed |
| CN-108567765-A | A kind of tumor microenvironment dual responsiveness medicine controlled releasing microcapsules and its application based on natural polysaccharide | 中国科学院宁波材料技术与工程研究所 | 2018-09-25 | — | — | CN | claimed |
| US-10010626-B2 | Molecular constructs with targeting and effector moieties | Immunwork Inc. (TW) | 2018-07-03 | — | — | US | claimed |
| US-9944750-B2 | Polyethylene glycol substituted acyl borates | ETH ZURICH (CH) | 2018-04-17 | — | — | US | claimed |
| US-20160339116-A1 | Molecular constructs with targeting and effector moieties for treating infectious diseases | Immunwork Inc. (TW) | 2016-11-24 | — | — | US | claimed |
| WO-2016112870-A1 | MOLECULAR CONSTRUCTS WITH TARGETING AND EFFECTOR ELEMENTS | CHANG TSE-WEN (CN) | 2016-07-21 | — | — | WO | claimed |
| US-20160208021-A1 | Molecular constructs with targeting and effector moieties | Immunwork Inc. (TW) | 2016-07-21 | — | — | US | claimed |
| EP-2818867-A1 | Antibodies conjugated to at least one nucleic acid molecule and their use in multiplex immuno-detection assays | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2014-12-31 | — | — | EP | claimed |
| EP-2793947-A2 | ENZYMATIC CONJUGATION OF POLYPEPTIDES | Innate Pharma (FR) | 2014-10-29 | — | — | EP | claimed |
| US-20130189287-A1 | ENZYMATIC CONJUGATION OF POLYPEPTIDES | PAUL SCHERRER INSTITUT | 2013-07-25 | — | — | US | claimed |
| WO-2013092983-A2 | ENZYMATIC CONJUGATION OF POLYPEPTIDES | INNATE PHARMA (FR) | 2013-06-27 | — | — | WO | claimed |
| US-8124282-B2 | Nonaqueous electrolyte having maleimide additives and secondary cells employing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-02-28 | — | — | US | claimed |
| US-20080160418-A1 | NONAQUEOUS ELECTROLYTE HAVING MALEIMIDE ADDITIVES AND SECONDARY CELLS EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2008-07-03 | — | — | US | claimed |
| EP-0611376-B1 | PRODUCTION AND USE OF MULTIMERIC HEMOGLOBINS | SOMATOGEN INC (US) | 1998-06-17 | — | — | EP | claimed |